Maintenance of Remission Among Patients with Crohn’s Disease on Anti-Metabolite Therapy after Infliximab Therapy is Stopped.

Louis E, Mary JY, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Dupas JL, Pillant H, Picon L, Veyrac M, Flamant M, Savoye G, Jian R, Devos M, Porcher R, Paintaud G, Piver E, Colombel JF, Lemann M;

(Gastroenterology 2012; 142: 63-70 – PMID: 21945953)

https://pubmed.ncbi.nlm.nih.gov/21945953/